MYO5BP1

Across TCGA pan-cancer cohorts, MYO5BP1 RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of MYO5BP1’s most consistent transcriptional readouts.

The strongest signal is observed in stomach adenocarcinoma (STAD), where MYO5BP1 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types MYO5BP1 is over-expressed in tumor.

STAD, BRCA, and BLCA are the cancer types where MYO5BP1 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in MYO5BP1 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
STAD	Female	All	+0.068	.003	4	view →
BRCA	All	All	+0.008	.036	4	view →
BLCA	Male	All	+0.032	.028	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

MYO5BP1–STAD

Open the STAD breakdown →